Analytical Data
-
基因名
EMR1
- Application
-
别名
TM7LN3; EGF-like module receptor 1; EMR1 hormone receptor
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q14246
-
表达区间
Met1~Pro201
-
分子量
29kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EMR1 (Epithelial Mucinosis Receptor 1) is a member of the epidermal growth factor (EGF) receptor family, predominantly expressed in specific immune cells, including macrophages and dendritic cells. Recent studies have highlighted the role of EMR1 in modulating immune responses, particularly in the context of inflammation and allergic reactions. Its unique ability to influence the activation and functional polarization of immune cells makes EMR1 an important target for understanding the pathways underlying various diseases, including asthma and autoimmune disorders. The production and characterization of EMR1 recombinant proteins are essential for elucidating its biological functions and interaction mechanisms. By generating a high-purity EMR1 protein through techniques such as recombinant DNA technology, researchers can explore its structural properties and biological activities, facilitating the development of potential therapeutic strategies. Understanding the signaling pathways involving EMR1 may provide insights into novel immunotherapeutic approaches and enhance our knowledge of its implications in health and disease. Therefore, the investigation of EMR1 recombinant protein serves as a pivotal step in advancing our comprehension of immune regulation and its potential applications in clinical settings.
